A Smartphone App Designed to Help Cancer Patients Stop Smoking: Results From a Pilot Randomized Trial on Feasibility, Acceptability, and Effectiveness
Open accessPublished version of a preprint
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Background: Persistent smoking after a cancer diagnosis predicts worse treatment outcomes and mortality, but access to effective smoking cessation interventions is limited. Smartphone apps can address this problem by providing a highly accessible, low-cost smoking cessation intervention designed for patients with a recent cancer diagnosis. Objective: This study aimed to summarize our development process and report the trial design, feasibility, participant acceptability, preliminary effectiveness, and impact on processes of change (eg, cancer stigma) of the first-known smoking cessation smartphone app targeted for cancer patients. Methods: We used an agile, user-centered design framework to develop a fully automated smartphone app called Quit2Heal that provided skills training and stories from cancer survivors focusing on coping with internalized shame, cancer stigma, depression, and anxiety as core triggers of smoking. Quit2Heal was compared with the National Cancer Institute’s QuitGuide, a widely used stop smoking app for the general population, in a pilot double-blinded randomized trial with a 2-month follow-up period. Participants were 59 adult smokers diagnosed with cancer within the past 12 months and recruited through 2 cancer center care networks and social media over a 12-month period. The most common types of cancer diagnosed were lung (21/59, 36%) and breast (10/59, 17%) cancers. The 2-month follow-up survey retention rate was 92% (54/59) and did not differ by study arm (P=.15). Results: Compared with QuitGuide participants, Quit2Heal participants were more satisfied with their assigned app (90% [19/21] for Quit2Heal vs 65% [17/26] for QuitGuide; P=.047) and were more likely to report that the app assigned to them was made for someone like them (86% [18/21] for Quit2Heal vs 62% [16/26] for QuitGuide; P=.04). Quit2Heal participants opened their app a greater number of times during the 2-month trial period, although this difference was not statistically significant (mean 10.0, SD 14.40 for Quit2Heal vs mean 6.1, SD 5.3 for QuitGuide; P=.33). Self-reported 30-day point prevalence quit rates at the 2-month follow-up were 20% (5/25) for Quit2Heal versus 7% (2/29) for QuitGuide (odds ratio 5.16, 95% CI 0.71-37.29; P=.10). Quit2Heal participants also showed greater improvement in internalized shame, cancer stigma, depression, and anxiety, although these were not statistically significant (all P>.05). Conclusions: In a pilot randomized trial with a high short-term retention rate, Quit2Heal showed promising acceptability and effectiveness for helping cancer patients stop smoking. Testing in a full-scale randomized controlled trial with a longer follow-up period and a larger sample size is required to test the effectiveness, mediators, and moderators of this promising digital cessation intervention. Trial Registration: ClinicalTrials.gov NCT03600038; https://clinicaltrials.gov/ct2/show/NCT03600038
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With a sample of 422 (211 in each arm), wherein missing outcome data is imputed as smoking, if we observe a 13.6% 30-day PPA at the 12-month follow-up in the Quit2Heal arm and a 4.7% 30-day PPA at the 12-month follow-up in the QuitGuide arm, we will have at least 80% power to detect a clinically meaningful difference in smoking cessation between treatment arms.”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These estimates are based on the self-reported quit rates at the 2-month follow-up observed in the Quit2Heal pilot trial, relapse by 12 months, and participant outcome data attrition.28,61–63”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“our research team followed an agile, user-centered design framework27 to develop the first known smartphone app (called “Quit2Heal”) specifically designed to help cancer patients quit smoking.28”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Self-reported 30-day point prevalence abstinence (PPA) rates were 20% for Quit2Heal vs. 7% for QuitGuide (OR=5.16; 95% CI: 0.71-37.29; p=.10) at the 2-month follow-up.”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Compared to QuitGuide participants, Quit2Heal participants showed greater improvements in shame, stigma, depression, and anxiety, albeit not statistically significant (all p>.05).”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 3×
“1 | e16652 | p. 7http://formative.jmir.org/2020/1/e16652/ (page number not for citation purposes) XSL•FO RenderX P valueQuit2Heal (N=29)a QuitGuide (N=30)a Total (N=59)a 4 (1/26)24 (5/21)13 (6/47)IV .235.3 (3.3)4.2 (3.7)4.7 (3.5)Months since initial diagnosis, mean (SD) Type of standard cancer treatment completed, % (…”
BackgroundMethodInfluentialScreening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30622-6 · Cited by 5,403
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · PubMed · Cited by 4,426
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Prevalence of depression in patients with cancer
Massie, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh014 · Cited by 1,408 · cited 1×
“Building on the promise of apps for the general population of smokers, a targeted intervention can address the unique processes that impede cessation among cancer patients, including shame about being a smoker, cancer stigma (feeling socially rejected for having caused one’s cancer), depression, and anxiety [35-44].”
BackgroundHEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., RICKERT, W., & ROBINSON, J. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03059.x · Cited by 1,313 · cited 1×
“We used computer-generated randomly permuted block randomization, stratified by Heaviness of Smoking Index (score>4 [55]), confidence in being smoke-free >70 (on a scale of 0-100), and recruitment method”
MethodMobile phone-based interventions for smoking cessation
Whittaker, R., McRobbie, H., Bullen, C., Rodgers, A., & Gu, Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006611.pub4 · Cited by 1,079 · cited 1×
“These sociodemographic groups are typically underrepresented in eHealth and mHealth smoking cessation research [73], although they experience significant disparities in the prevalence and negative health consequences of smoking [74].”
BackgroundTelephone counselling for smoking cessation
Stead, L. F., Hartmann-Boyce, J., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002850.pub3 · Cited by 1,003 · cited 3×
“Self-reported smoking is a standard method for assessing the efficacy of low-intensity interventions [68,69].”
BackgroundMethodFife, B. L., & Wright, E. R. (2000) · Journal of Health and Social Behavior · doi:10.2307/2676360 · Cited by 858
The Use of Facebook in Recruiting Participants for Health Research Purposes: A Systematic Review
Whitaker, C., Stevelink, S., & Fear, N. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7071 · Cited by 724 · cited 1×
“For reporting readily comparable Facebook recruitment metrics [53,54], the Facebook cost per click, result rate (formerly called conversion rate), and impressions were US $0.”
BackgroundParsons, A., Daley, A., Begh, R., & Aveyard, P. (2010) · BMJ · doi:10.1136/bmj.b5569 · Cited by 696 · cited 2×
“In contrast, quitting smoking after receiving a cancer diagnosis greatly reduces the risk of poor treatment outcomes [5,15] and of a second primary cancer [11,12] and lowers the mortality rates [5,13,14].”
BackgroundSørensen, L. T. (2012) · Archives of Surgery · doi:10.1001/archsurg.2012.5 · Cited by 645
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
Browman, G. P., Wong, G., Hodson, I., Sathya, J., Russell, R., McAlpine, L., Skingley, P., & Levine, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280302 · Cited by 600 · cited 1×
“Compared with patients who quit smoking after their diagnosis, cancer patients who remain smokers have worse treatment outcomes, including 2 to 4 times higher risk of nonresponse to radiation [5-7], decreased efficacy and tolerance of chemotherapy [8,9], and 2 to 3.”
BackgroundWho's still smoking? Disparities in adult cigarette smoking prevalence in the United States
Drope, J., Liber, A. C., Cahn, Z., Stoklosa, M., Kennedy, R., Douglas, C. E., Henson, R., & Drope, J. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21444 · Cited by 395 · cited 1×
“These sociodemographic groups are typically underrepresented in eHealth and mHealth smoking cessation research [73], although they experience significant disparities in the prevalence and negative health consequences of smoking [74].”
BackgroundiPhone Apps for Smoking Cessation
Abroms, L. C., Padmanabhan, N., Thaweethai, L., & Phillips, T. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.10.032 · Cited by 365
Bricker, J. B., Mull, K. E., Kientz, J. A., Vilardaga, R., Mercer, L. D., Akioka, K. J., & Heffner, J. L. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.07.006 · Cited by 340
Self-citationRecruiting for health, medical or psychosocial research using Facebook: Systematic review
Thornton, L., Batterham, P. J., Fassnacht, D. B., Kay-Lambkin, F., Calear, A. L., & Hunt, S. (2016) · Internet Interventions · doi:10.1016/j.invent.2016.02.001 · Cited by 326
A Content Analysis of Popular Smartphone Apps for Smoking Cessation
Abroms, L. C., Lee Westmaas, J., Bontemps-Jones, J., Ramani, R., & Mellerson, J. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.07.008 · Cited by 325 · cited 2×
“Apps do not require provider training, reimbursement for cessation interventions, or integration into complex hospital systems (eg, apps can be freely accessed on an app store), and they are available anytime at arm’s reach [28-30].”
BackgroundMethodSelf-citationEffects of smoking on the pharmacokinetics of erlotinib
Hamilton, M., Wolf, J. L., Rusk, J., Beard, S. E., Clark, G. M., Witt, K., & Cagnoni, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2235 · Cited by 312 · cited 1×
“Compared with patients who quit smoking after their diagnosis, cancer patients who remain smokers have worse treatment outcomes, including 2 to 4 times higher risk of nonresponse to radiation [5-7], decreased efficacy and tolerance of chemotherapy [8,9], and 2 to 3.”
BackgroundWarren, G. W., Alberg, A. J., Kraft, A. S., & Cummings, K. M. (2014) · Cancer · doi:10.1002/cncr.28695 · Cited by 298
Smoking at diagnosis and survival in cancer patients
Warren, G. W., Kasza, K. A., Reid, M. E., Cummings, K. M., & Marshall, J. R. (2013) · International Journal of Cancer · doi:10.1002/ijc.27617 · Cited by 265 · cited 3×
“In contrast, quitting smoking after receiving a cancer diagnosis greatly reduces the risk of poor treatment outcomes [5,15] and of a second primary cancer [11,12] and lowers the mortality rates [5,13,14].”
BackgroundTeachable Moments for Promoting Smoking Cessation: The Context of Cancer Care and Survivorship
Mcbride, C. M., & Ostroff, J. S. (2003) · Cancer Control · doi:10.1177/107327480301000407 · Cited by 238 · cited 2×
“To guide the adaptation of iCanQuit for cancer patients who smoke, we interviewed smoking cessation clinicians at 4 NCI-designated cancer centers across the United States and reviewed (1) the empirical studies on the factors that influence quitting smoking in cancer patients (ie, shame, stigma, depression, and anxiety…”
BackgroundMethodSelf-citationThe Relationship Between Cigarette Smoking and Quality of Life After Lung Cancer Diagnosis
Garces, Y. I., Yang, P., Parkinson, J., Zhao, X., Wampfler, J. A., Ebbert, J. O., & Sloan, J. A. (2004) · Chest · doi:10.1378/chest.126.6.1733 · Cited by 237 · cited 1×
“Unfortunately, up to 80% of smokers with cancer continue to smoke after their diagnosis [2,18-20].”
BackgroundLU, J., EPPLER, S., WOLF, J., HAMILTON, M., RAKHIT, A., BRUNO, R., & LUM, B. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.04.007 · Cited by 227 · cited 1×
“Compared with patients who quit smoking after their diagnosis, cancer patients who remain smokers have worse treatment outcomes, including 2 to 4 times higher risk of nonresponse to radiation [5-7], decreased efficacy and tolerance of chemotherapy [8,9], and 2 to 3.”
BackgroundA systematic review of smartphone applications for smoking cessation
Haskins, B. L., Lesperance, D., Gibbons, P., & Boudreaux, E. D. (2017) · Translational Behavioral Medicine · doi:10.1007/s13142-017-0492-2 · Cited by 227 · cited 1×
“Smartphone apps for smoking cessation are showing solid promise among the general population of smokers [33].”
BackgroundHollis, J. F., McAfee, T. A., Fellows, J. L., Zbikowski, S. M., Stark, M., & Riedlinger, K. (2007) · Tobacco Control · doi:10.1136/tc.2006.019794 · Cited by 222
The state of Cancer Care in America, 2017: a report by the American Society of Clinical Oncology
The American Society of Clinical Oncology (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.020743 · Cited by 204
Eifel, P. J., Jhingran, A., Bodurka, D. C., Levenback, C., & Thames, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.128 · Cited by 201 · cited 1×
“Compared with patients who quit smoking after their diagnosis, cancer patients who remain smokers have worse treatment outcomes, including 2 to 4 times higher risk of nonresponse to radiation [5-7], decreased efficacy and tolerance of chemotherapy [8,9], and 2 to 3.”
BackgroundMultilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum
Hamann, H. A., Ver Hoeve, E. S., Carter-Harris, L., Studts, J. L., & Ostroff, J. S. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.014 · Cited by 183 · cited 1×
“Building on the promise of apps for the general population of smokers, a targeted intervention can address the unique processes that impede cessation among cancer patients, including shame about being a smoker, cancer stigma (feeling socially rejected for having caused one’s cancer), depression, and anxiety [35-44].”
BackgroundSelf-citationBuller, D. B., Borland, R., Bettinghaus, E. P., Shane, J. H., & Zimmerman, D. E. (2014) · Telemedicine and e-Health · doi:10.1089/tmj.2013.0169 · Cited by 178 · cited 2×
“Apps do not require provider training, reimbursement for cessation interventions, or integration into complex hospital systems (eg, apps can be freely accessed on an app store), and they are available anytime at arm’s reach [28-30].”
BackgroundMethodCroyle, R. T., Morgan, G. D., & Fiore, M. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmp1813913 · Cited by 173 · cited 1×
“In direct response to this need, the US NCI created a Moonshot-funded Cancer Center Cessation Initiative (C3I) to support the implementation of evidence-based cessation interventions at 42 NCI-designated cancer centers [25].”
BackgroundBricker, J., Wyszynski, C., Comstock, B., & Heffner, J. L. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt056 · Cited by 170 · cited 1×
“Our original recruitment goal was 200 participants (100 per arm) based on our experience with recruiting 200 participants in prior pilot randomized trials of mobile health (mHealth) and electronic health (eHealth) for smoking cessation for the general population of smokers [51,52].”
BackgroundSelf-citationWarren, G. W., Marshall, J. R., Cummings, K. M., Toll, B. A., Gritz, E. R., Hutson, A., Dibaj, S., Herbst, R., Mulshine, J. L., Hanna, N., et al. (2013) · Journal of Oncology Practice · doi:10.1200/jop.2013.001025 · Cited by 168 · cited 2×
“Barriers to access also include the lack of insurance coverage; the lack of clinical staff training and time; and the lack of systems for universal assessment, referral, and integration of cessation service into routine cancer care [23,24].”
BackgroundSmoking relapse during the first year after treatment for early-stage non-small-cell lung cancer
Walker, M. S., Vidrine, D. J., Gritz, E. R., Larsen, R. J., Yan, Y., Govindan, R., & Fisher, E. B. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0509 · Cited by 147 · cited 1×
“Moreover, 15% to 25% of those who do quit after a cancer diagnosis will return to smoking within 12 months [4,21,22].”
BackgroundSmoking cessation, version 1.2016, NCCN clinical practice guidelines in oncology
Shields, P. G., Herbst, R. S., Arenberg, D., Benowitz, N. L., Bierut, L., Luckart, J. B., Cinciripini, P., Collins, B., David, S., Davis, J., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0152 · Cited by 146 · cited 3×
“gov website, a well-established eHealth intervention resource recommended by the NCCN Clinical Practice Guidelines for cancer patients’ smoking cessation [17]; (3) QuitGuide is one of the few apps (of over 500 available) that follow the US Clinical Practice Guidelines [60]; and (4) QuitGuide is nonproprietary and free…”
BackgroundMethodHutton, H. E., Wilson, L. M., Apelberg, B. J., Avila Tang, E., Odelola, O., Bass, E. B., & Chander, G. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq252 · Cited by 132 · cited 2×
“Self-reported smoking is a standard method for assessing the efficacy of low-intensity interventions [68,69].”
MethodThe risk of second primary tumors after resection of stage I nonsmall cell lung cancer
Rice, D. C., Kim, H.-W., Sabichi, A. L., Lippman, S. M., Lee, J. J., Williams, B., Vaporciyan, A. A., Smythe, W. R., Swisher, S. G., Walsh, G. L., et al. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)00821-x · Cited by 126 · cited 2×
“In contrast, quitting smoking after receiving a cancer diagnosis greatly reduces the risk of poor treatment outcomes [5,15] and of a second primary cancer [11,12] and lowers the mortality rates [5,13,14].”
BackgroundSmoking cessation and lung cancer resection
Dresler, C. M., Bailey, M., Roper, C. R., Patterson, G. A., & Cooper, J. D. (1996) · Chest · doi:10.1378/chest.110.5.1199 · Cited by 119 · cited 1×
“Moreover, 15% to 25% of those who do quit after a cancer diagnosis will return to smoking within 12 months [4,21,22].”
BackgroundWatson, N. L., Mull, K. E., Heffner, J. L., McClure, J. B., & Bricker, J. B. (2018) · Journal of Medical Internet Research · doi:10.2196/10351 · Cited by 118 · cited 2×
“The procedures for follow-up data collection were modeled after the procedures that have been successful in our previous trials at maximizing data retention [52,61,62].”
MethodResultSelf-citationA snapshot of smokers after lung and colorectal cancer diagnosis
Park, E. R., Japuntich, S. J., Rigotti, N. A., Traeger, L., He, Y., Wallace, R. B., Malin, J. L., Zallen, J. P., & Keating, N. L. (2012) · Cancer · doi:10.1002/cncr.26545 · Cited by 117 · cited 1×
“In the United States, 15% to 54% of cancer patients are cigarette smokers at the time of their diagnosis [1-4].”
BackgroundBinDhim, N. F., McGeechan, K., & Trevena, L. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-017105 · Cited by 116
Wells, M., Aitchison, P., Harris, F., Özakinci, G., Radley, A., Bauld, L., Entwistle, V. A., Munro, A., Haw, S. J., Culbard, B., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3344-z · Cited by 111
Tseng, T.-S., Lin, H.-Y., Moody-Thomas, S., Martin, M., & Chen, T. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-784 · Cited by 110
Tobacco Use in the Oncology Setting: Advancing Clinical Practice and Research
Gritz, E. R., Toll, B. A., & Warren, G. W. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0896 · Cited by 104 · cited 1×
“In contrast, quitting smoking after receiving a cancer diagnosis greatly reduces the risk of poor treatment outcomes [5,15] and of a second primary cancer [11,12] and lowers the mortality rates [5,13,14].”
BackgroundCorrelates of continued smoking versus cessation among survivors of smoking-related cancers
Berg, C. J., Thomas, A. N., Mertens, A. C., Schauer, G. L., Pinsker, E. A., Ahluwalia, J. S., & Khuri, F. R. (2013) · Psycho-Oncology · doi:10.1002/pon.3077 · Cited by 97 · cited 1×
“Building on the promise of apps for the general population of smokers, a targeted intervention can address the unique processes that impede cessation among cancer patients, including shame about being a smoker, cancer stigma (feeling socially rejected for having caused one’s cancer), depression, and anxiety [35-44].”
BackgroundTobacco Use Treatment at the U.S. National Cancer Institute's Designated Cancer Centers
Goldstein, A. O., Ripley-Moffitt, C. E., Pathman, D. E., & Patsakham, K. M. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts083 · Cited by 93
Tabuchi, T., Ito, Y., Ioka, A., Nakayama, T., Miyashiro, I., & Tsukuma, H. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt279 · Cited by 91 · cited 2×
“In contrast, quitting smoking after receiving a cancer diagnosis greatly reduces the risk of poor treatment outcomes [5,15] and of a second primary cancer [11,12] and lowers the mortality rates [5,13,14].”
BackgroundBricker, J. B., Mull, K. E., McClure, J. B., Watson, N. L., & Heffner, J. L. (2018) · Addiction · doi:10.1111/add.14127 · Cited by 91 · cited 1×
“The procedures for follow-up data collection were modeled after the procedures that have been successful in our previous trials at maximizing data retention [52,61,62].”
MethodSelf-citationBurris, J. L., Studts, J. L., DeRosa, A. P., & Ostroff, J. S. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0257 · Cited by 90 · cited 2×
“Moreover, 15% to 25% of those who do quit after a cancer diagnosis will return to smoking within 12 months [4,21,22].”
BackgroundSelf-citationRoy, M., Dum, M., Sobell, L. C., Sobell, M. B., Simco, E. R., Manor, H., & Palmerio, R. (2008) · Substance Use & Misuse · doi:10.1080/10826080802347586 · Cited by 85 · cited 1×
“At baseline, participants reported their demographics, cancer (eg, type and stage), alcohol use (Quick Drinking Screen [63]), current and past tobacco use, nicotine dependence (Fagerstrom Test for Nicotine Dependence; FTND [64]), confidence in quitting, and smoking in the social environment.”
MethodBérubé, S., Lemieux, J., Moore, L., Maunsell, E., & Brisson, J. (2014) · Breast Cancer Research · doi:10.1186/bcr3646 · Cited by 85 · cited 1×
“In the United States, 15% to 54% of cancer patients are cigarette smokers at the time of their diagnosis [1-4].”
BackgroundDepression and smoking cessation: evidence from a smoking cessation clinic with 1-year follow-up
Stepankova, L., Kralikova, E., Zvolska, K., Pankova, A., Ovesna, P., Blaha, M., & Brose, L. S. (2017) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9869-6 · Cited by 78 · cited 2×
“To guide the adaptation of iCanQuit for cancer patients who smoke, we interviewed smoking cessation clinicians at 4 NCI-designated cancer centers across the United States and reviewed (1) the empirical studies on the factors that influence quitting smoking in cancer patients (ie, shame, stigma, depression, and anxiety…”
BackgroundMethodD'Angelo, H., Rolland, B., Adsit, R., Baker, T. B., Rosenblum, M., Pauk, D., Morgan, G. D., & Fiore, M. C. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0182 · Cited by 74 · cited 1×
“The C3I is making progress in implementing treatment programs within the 42 participating NCI cancer centers [26] but is hindered by the complex tobacco treatment delivery challenges of limited hospital resources, inadequate clinical staff training, and clinic workflows [26].”
MethodLung cancer stigma and depression: validation of the lung cancer stigma inventory
Ostroff, J. S., Riley, K. E., Shen, M. J., Atkinson, T. M., Williamson, T. J., & Hamann, H. A. (2019) · Psycho-Oncology · doi:10.1002/pon.5033 · Cited by 54 · cited 5×
“The brief process measures, assessed at baseline and the 2-month follow-up, were internalized shame (5-item internalized shame subscale of the Social Impact Scale [65]), internalized stigma (9-item internalized stigma subscale of the Lung Cancer Stigma Inventory [35]), depression (10-item Center for Epidemiologic Stud…”
BackgroundMethodInfluentialSelf-citationWhy do cancer patients smoke and what can providers do about it?
Duffy, S. A., Louzon, S. A., & Gritz, E. R. (2012) · Community Oncology · doi:10.1016/j.cmonc.2012.10.003 · Cited by 52
Li, W. H. C., Wang, M. P., Ho, K. Y., Lam, K. K. W., Cheung, Y. T. D., Cheung, Y. T. Y., Lam, T., & Chan, S. S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-21207-1 · Cited by 45 · cited 1×
“To guide the adaptation of iCanQuit for cancer patients who smoke, we interviewed smoking cessation clinicians at 4 NCI-designated cancer centers across the United States and reviewed (1) the empirical studies on the factors that influence quitting smoking in cancer patients (ie, shame, stigma, depression, and anxiety…”
MethodSchnoll, R. A., Leone, F. T., Veluz‐Wilkins, A. K., Miele, A., Hole, A. V., Jao, N. C., Wileyto, E. P., Carroll, A. J., Kalhan, R., Patel, J. D., et al. (2019) · Psycho-Oncology · doi:10.1002/pon.4978 · Cited by 43
Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit
Paul, C. L., Tzelepis, F., Boyes, A. W., D’Este, C., Sherwood, E., & Girgis, A. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00787-5 · Cited by 42 · cited 1×
“Unfortunately, up to 80% of smokers with cancer continue to smoke after their diagnosis [2,18-20].”
BackgroundShin, D. W., Park, J. H., Kim, S. Y., Park, E. W., Yang, H. K., Ahn, E., Park, S. M., Lee, Y. J., Lim, M. C., & Seo, H. G. (2014) · Psycho-Oncology · doi:10.1002/pon.3460 · Cited by 41 · cited 1×
“Building on the promise of apps for the general population of smokers, a targeted intervention can address the unique processes that impede cessation among cancer patients, including shame about being a smoker, cancer stigma (feeling socially rejected for having caused one’s cancer), depression, and anxiety [35-44].”
BackgroundShame, guilt, and communication in lung cancer patients and their partners
Dirkse, D., Lamont, L., Li, Y., Simonič, A., Bebb, G., & Giese–Davis, J. (2014) · Current Oncology · doi:10.3747/co.21.2034 · Cited by 39 · cited 2×
“To guide the adaptation of iCanQuit for cancer patients who smoke, we interviewed smoking cessation clinicians at 4 NCI-designated cancer centers across the United States and reviewed (1) the empirical studies on the factors that influence quitting smoking in cancer patients (ie, shame, stigma, depression, and anxiety…”
BackgroundMethodPark, E. R., Ostroff, J. S., Perez, G. K., Hyland, K. A., Rigotti, N. A., Borderud, S. P., Regan, S., Muzikansky, A., Friedman, E. R., Levy, D. E., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.07.016 · Cited by 33 · cited 2×
“To guide the adaptation of iCanQuit for cancer patients who smoke, we interviewed smoking cessation clinicians at 4 NCI-designated cancer centers across the United States and reviewed (1) the empirical studies on the factors that influence quitting smoking in cancer patients (ie, shame, stigma, depression, and anxiety…”
MethodSelf-citationCigarette smoking and survival after ovarian cancer diagnosis
Nagle, C. M., Bain, C. J., & Webb, P. M. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0592 · Cited by 31 · cited 2×
“In contrast, quitting smoking after receiving a cancer diagnosis greatly reduces the risk of poor treatment outcomes [5,15] and of a second primary cancer [11,12] and lowers the mortality rates [5,13,14].”
BackgroundUser-centered design to develop clinical applications. Literature review
Luna, D. R., María, Q., Zulma, G., Alemrares, A., Risk, M. R., Mauro, G. A., & Otero, C. (2015) · Studies in health technology and informatics · doi:10.3233/978-1-61499-564-7-967 · Cited by 31 · cited 1×
“We used an iterative, user-centered design approach [45] to develop an app designed to help cancer patients quit smoking.”
MethodHeffner, J. L., & Mull, K. E. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7953 · Cited by 29 · cited 1×
“Apps have potentially high population-level reach to cancer patients—especially given that over three-quarters (76%) of all smokers own smartphones, and 68% of adults aged 55 to 74 years own smartphones [31,32].”
BackgroundSelf-citationGhosh, A., Philiponis, G., Bewley, A. F., Ransom, E. R., & Mirza, N. A. (2016) · The Journal of Laryngology & Otology · doi:10.1017/s0022215116000037 · Cited by 26
Luberto, C. M., Hyland, K. A., Streck, J. M., Temel, B., & Park, E. R. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw166 · Cited by 19 · cited 1×
“Building on the promise of apps for the general population of smokers, a targeted intervention can address the unique processes that impede cessation among cancer patients, including shame about being a smoker, cancer stigma (feeling socially rejected for having caused one’s cancer), depression, and anxiety [35-44].”
BackgroundBlanchard, E. M., Mulvey, T. M., & Hamilton, M. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.e17699 · Cited by 2 · cited 1×
“Unfortunately, up to 80% of smokers with cancer continue to smoke after their diagnosis [2,18-20].”
Background
Research works printed but not linked: 1
- Luna, D, 2015, Stud Health Technol Inform, 216, 967
Cited by
Challenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review
Amagai, S., Pila, S., Kaat, A. J., Nowinski, C. J., & Gershon, R. C. (2022) · Journal of Medical Internet Research · doi:10.2196/35120 · Cited by 343
Prutzman, Y. M., Wiseman, K. P., Grady, M. A., Budenz, A., Grenen, E. G., Vercammen, L. K., Keefe, B., & Bloch, M. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.08.008 · Cited by 57
Lung cancer stigma and depression: validation of the lung cancer stigma inventory
Ostroff, J. S., Riley, K. E., Shen, M. J., Atkinson, T. M., Williamson, T. J., & Hamann, H. A. (2019) · Psycho-Oncology · doi:10.1002/pon.5033 · Cited by 54
Self-citationKiss, N. K., Jongebloed, H., Baguley, B. J., Marshall, S., WHITE, V. M., Livingston, P. M., Bell, K., Young, L., Sabesan, S. S., Swiatek, D., et al. (2024) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkae048 · Cited by 51
Mobile health interventions for cancer patient education: A scoping review
Samadbeik, M., Garavand, A., Aslani, N., Sajedimehr, N., & Fatehi, F. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105214 · Cited by 35
Metadata
- Authors
- Bricker, J. B., Watson, N. L., Heffner, J. L., Sullivan, B., Mull, K., Kwon, D., Westmaas, J. L., & Ostroff, J.
- Affiliations
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- American Cancer Society (US)
- Corresponding author
- Bricker, Jonathan B
- ORCID
- Venue
- JMIR Formative Research
- Publisher
- JMIR Publications Inc.
- Published
- 2020-01-17
- Volume
- 4
- Issue
- 1
- Pages
- e16652
- ISSN
- 2561-326X (ISSN-L)
- PMC
- PMC6996729
- OpenAlex
- W2996162400
- Cited by
- 41
- References
- 69
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 9 · 2023: 9 · 2022: 12 · 2021: 2 · 2020: 2
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Formative Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Drug Abuse (R01DA038411)
- National Cancer Institute (R01CA192849, R01CA166646)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- smoking cessation, cancer patients, mobile application, cancer stigma, internalized shame, user-centered design, cancer survivors, lung cancer, breast cancer, mobile health intervention, app engagement, user-generated content, coping skills training
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
